Cargando…

Immunotoxin Therapy for Lung Cancer

Detalles Bibliográficos
Autores principales:	Xie, Li-Yi, Piao, Hai-Lan, Fan, Min, Zhang, Zhen, Wang, Chen, Bigner, Darell D, Bao, Xu-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339936/ https://www.ncbi.nlm.nih.gov/pubmed/28229994 http://dx.doi.org/10.4103/0366-6999.200540

Ejemplares similares

EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery
por: Bao, Xuhui, et al.
Publicado: (2016)

A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2013)

Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer
por: Xie, Liyi, et al.
Publicado: (2018)

Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2019)

Antitumor efficacy of D2C7-(scdsFv)-PE38KDEL, a novel immunotoxin targeting EGFRwt and EGFRvIII, by convection-enhanced delivery in orthotopic brain tumor mouse models
por: Bao, Xuhui, et al.
Publicado: (2013)

Cytotoxins and immunotoxins for cancer therapy : clinical applications /
Publicado: (2005)

Clinical targeting recombinant immunotoxins for cancer therapy
por: Li, Meng, et al.
Publicado: (2017)

Systemic immunotoxin therapy of cancer: advances and prospects.
por: Wawrzynczak, E. J.
Publicado: (1991)

Antibody-Based Immunotoxins for Colorectal Cancer Therapy
por: Sanz, Laura, et al.
Publicado: (2021)

Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy
por: Bokori-Brown, Monika, et al.
Publicado: (2018)

Toxin-Based Targeted Therapy for Malignant Brain Tumors
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2012)

Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma
por: Ehrlich, Debra, et al.
Publicado: (2014)

Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2011)

Immunotoxins: experimental design
por: Dall, P, et al.
Publicado: (2001)

Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013)

Countering immunotoxin immunogenicity
por: Flavell, David J
Publicado: (2016)

Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
por: Simon, Nathan, et al.
Publicado: (2016)

Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
por: Hosseinian, Seyed-Ali, et al.
Publicado: (2018)

Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview
por: Polito, Letizia, et al.
Publicado: (2016)

Mechanisms of Resistance to Immunotoxins Containing Pseudomonas Exotoxin A in Cancer Therapy
por: Dieffenbach, Michael, et al.
Publicado: (2020)

Recombinant immunotoxins development for HER2-based targeted cancer therapies
por: Mahmoudi, Reza, et al.
Publicado: (2021)

Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.
por: Wawrzynczak, E. J., et al.
Publicado: (1992)

Enzyme Redesign Guided by Cancer-Derived IDH1 Mutations
por: Reitman, Zachary J., et al.
Publicado: (2012)

Immunotoxins: A Review of Their Use in Cancer Treatment
por: Aruna, G
Publicado: (2006)

Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
por: Fleming, Bryan D., et al.
Publicado: (2016)

Treatment of solid tumors with immunotoxins
por: Messmer, Davorka, et al.
Publicado: (2005)

Bouganin, an Attractive Weapon for Immunotoxins
por: Bortolotti, Massimo, et al.
Publicado: (2018)

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
por: Marszalowicz, Glen P., et al.
Publicado: (2014)

Aberrant Otx2 Expression Enhances Migration and Induces Ectopic Proliferation of Hindbrain Neuronal Progenitor Cells
por: Wortham, Matthew, et al.
Publicado: (2012)

Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin
por: Flavell, D J, et al.
Publicado: (2001)

Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
por: Hagerty, Brendan L., et al.
Publicado: (2020)

Immunotoxins: From Design to Clinical Application
por: Kreitman, Robert J., et al.
Publicado: (2021)

Toxin and Immunotoxin Based Therapeutic Approaches
por: Bortolotti, Massimo, et al.
Publicado: (2022)

Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy
por: Ferreras, José M., et al.
Publicado: (2011)

A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system
por: Choi, Bryan D., et al.
Publicado: (2013)

Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy
por: Cui, Jian, et al.
Publicado: (2016)

Stemness and plasticity of lung cancer cells: paving the road for better therapy
por: Luo, Judong, et al.
Publicado: (2014)

CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin
por: Ma, Jingbo, et al.
Publicado: (2022)

Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
por: Fleming, Bryan D., et al.
Publicado: (2020)

Successful therapy with bevacizumab combined with corticosteroids for crizotinib-induced interstitial lung disease
por: Xie, Xiaohong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_crlmvdpcdpk69qke2oatmvu7ag